Latest news
VERAXA Biotech (VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC® Cancer Therapy Platform - NewMediaWireNewMediaWire · Thu, 30 Jul 2026 18:55:50 GMTRegentis Biomaterials (RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin C - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMT